Nobivac® Feline 1-HCP

Feline 1-HCP

A quality core vaccine shown to be effective for vaccination of healthy cats 9 weeks of age or older against feline rhinotracheitis, calici, and panleukopenia viruses.

Product Description

NOBIVAC® FELINE 1-HCP Vaccine provides triple virus protection

Feline Rhinotracheitis Virus, Feline Calicivirus, Feline Panleukopenia Virus (modified live viruses).

A quality core vaccine shown to be effective for vaccination of healthy cats 9 weeks of age or older against feline rhinotracheitis, calici, and panleukopenia viruses.
Effective against the most common threatening viral infections—calicivirus, herpesvirus, and the deadly feline parvovirus, panleukopenia
Nobivac® Feline 1-HCP has been shown to block the replication of canine parvovirus (CPV) in cats¹
- Evidence shows that CPV-2a, CPV-2b, and CPV-2c isolates can replicate in cats, producing clinical signs of feline panleukopenia^62-63
Non-adjuvanted formula
Optimal choice for healthy indoor cats

product Label

Overview

Administration

Alternate

Disease Information

Indications

Shown to be effective for vaccination of healthy cats 9 weeks of age or older against feline rhinotracheitis, calici, and panleukopenia viruses.

ADMINISTRATION AND DOSAGE

Subcutaneous or intramuscular injection
Initial 1 mL dose administered at 9 weeks of age or older
Second 1 mL dose administered 3 to 4 weeks later
Historically, annual revaccination has been recommended for this product. The need for this booster has not been established. For more information on revaccination frequency, in general or in the face of maternal antibody, consult your veterinarian or the manufacturer.
Available in a 25 x 1 mL dose presentation